Literature DB >> 32943150

Strategies for the expression and characterization of artificial myoglobin-based carbene transferases.

Daniela M Carminati1, Eric J Moore1, Rudi Fasan2.   

Abstract

Myoglobin has recently emerged as a versatile metalloprotein scaffold for the design of efficient and selective biocatalysts for abiological carbene transfer reactions, including asymmetric cyclopropanation reactions. Over the past few years, our group has explored several strategies to modulate the carbene transfer reactivity of myoglobin-based catalysts, including the substitution of the native heme cofactor and conserved histidine axial ligand with non-native porphynoid ligands and alternative natural and unnatural amino acids as the metal-coordinating ligands, respectively. Herein, we report protocols for the generation and reconstitution in vitro and in vivo of myoglobin-based artificial carbene transferases incorporating non-native iron-porphynoid cofactors, also in combination with unnatural amino acids as the proximal ligand. These strategies are effective for imparting these myoglobin-based cyclopropanation biocatalysts with altered and improved function, including tolerance to aerobic conditions and improved reactivity toward electrondeficient olefins.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artificial metalloenzyme; Carbene transfer catalysis; Myoglobin; Noncanonical amino acids; Porphyrinoids

Mesh:

Substances:

Year:  2020        PMID: 32943150      PMCID: PMC8325922          DOI: 10.1016/bs.mie.2020.07.007

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  37 in total

1.  Cleavage of the haem-protein link by acid methylethylketone.

Authors:  F W TEALE
Journal:  Biochim Biophys Acta       Date:  1959-10

2.  Effect of proximal ligand substitutions on the carbene and nitrene transferase activity of myoglobin.

Authors:  Eric J Moore; Rudi Fasan
Journal:  Tetrahedron       Date:  2019-03-11       Impact factor: 2.457

3.  Origin of high stereocontrol in olefin cyclopropanation catalyzed by an engineered carbene transferase.

Authors:  Antonio Tinoco; Yang Wei; John-Paul Bacik; Daniela M Carminati; Eric J Moore; Nozomi Ando; Yong Zhang; Rudi Fasan
Journal:  ACS Catal       Date:  2018-12-28       Impact factor: 13.084

4.  Catalytic Cyclopropanation by Myoglobin Reconstituted with Iron Porphycene: Acceleration of Catalysis due to Rapid Formation of the Carbene Species.

Authors:  Koji Oohora; Hiroyuki Meichin; Liming Zhao; Matthew W Wolf; Akira Nakayama; Jun-Ya Hasegawa; Nicolai Lehnert; Takashi Hayashi
Journal:  J Am Chem Soc       Date:  2017-11-22       Impact factor: 15.419

5.  Selective Functionalization of Aliphatic Amines via Myoglobin-catalyzed Carbene N-H Insertion.

Authors:  Viktoria Steck; Gopeekrishnan Sreenilayam; Rudi Fasan
Journal:  Synlett       Date:  2019-07-11       Impact factor: 2.454

Review 6.  Myoglobin: an essential hemoprotein in striated muscle.

Authors:  George A Ordway; Daniel J Garry
Journal:  J Exp Biol       Date:  2004-09       Impact factor: 3.312

7.  Chemoselective Cyclopropanation over Carbene Y-H Insertion Catalyzed by an Engineered Carbene Transferase.

Authors:  Eric J Moore; Viktoria Steck; Priyanka Bajaj; Rudi Fasan
Journal:  J Org Chem       Date:  2018-07-06       Impact factor: 4.354

8.  Highly diastereoselective and enantioselective olefin cyclopropanation using engineered myoglobin-based catalysts.

Authors:  Melanie Bordeaux; Vikas Tyagi; Rudi Fasan
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-23       Impact factor: 15.336

9.  The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.

Authors:  Tanaji T Talele
Journal:  J Med Chem       Date:  2016-06-30       Impact factor: 7.446

10.  Systematic tuning of heme redox potentials and its effects on O2 reduction rates in a designed oxidase in myoglobin.

Authors:  Ambika Bhagi-Damodaran; Igor D Petrik; Nicholas M Marshall; Howard Robinson; Yi Lu
Journal:  J Am Chem Soc       Date:  2014-08-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.